保留子宫手术治疗子宫腺肌病后的妊娠结局:系统综述与Meta分析
该系统综述与Meta分析纳入13项研究共1319例子宫腺肌病患者(其中795例有生育要求),评估保留子宫手术后的妊娠结局。病灶切除术后的妊娠率、流产率和活产率分别为40%、21%和70%,非切除术式分别为51%、22%和71%,差异无统计学意义。作者认为病灶切除术可考虑用于有症状且不孕数年或辅助生殖技术反复失败的患者,非切除术式可考虑用于子宫腺肌病相关不孕。
要点
- 病灶切除术后妊娠率40%、流产率21%、活产率70%,非切除术式分别为51%、22%、71%,差异无统计学意义。
- 作者认为病灶切除术可考虑用于有症状且不孕数年或辅助生殖技术反复失败的患者。
- 作者认为非切除术式可考虑用于子宫腺肌病相关不孕。
核心结论
- 病灶切除术可考虑用于有症状且不孕数年或辅助生殖技术反复失败的患者。
- 非切除术式可考虑用于子宫腺肌病相关不孕。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Web of Science、Cochrane Library和Embase从2000年1月至2022年1月的文献。
- 纳入所有报告有生育要求的子宫腺肌病患者保留子宫手术生殖结局的研究。
- 共纳入13项研究、1319例子宫腺肌病患者,其中795例有生育要求。
- 手术方式分为病灶完全切除或不全切除,以及诱导病灶坏死的非切除术式(包括高强度聚焦超声、微波消融、射频消融和子宫动脉栓塞)。
- 由两名研究者独立按筛选标准进行研究选择。
主要发现
- 尝试妊娠者病灶切除术后妊娠率为40%(95%CI 29-52),流产率为21%(95%CI 16-27),活产率为70%(95%CI 64-76)。
- 非切除术式后相应妊娠率为51%(95%CI 42-60),流产率为22%(95%CI 13-34),活产率为71%(95%CI 57-83)。
- 病灶切除术与非切除术式之间的差异无统计学意义。
临床怎么用
- 作者认为病灶切除术可考虑用于有症状且不孕数年或辅助生殖技术反复失败的患者。
- 作者认为非切除术式可考虑用于子宫腺肌病相关不孕。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A meta-analysis was conducted to evaluate the overall pregnancy outcomes after uterus-sparing operative treatment in patients with adenomyosis (AD). DATA SOURCES: We searched PubMed, Web of Science, Cochrane Library, and Embase for literature from January 2000 to January 2022. METHODS OF STUDY SELECTION: We included all studies reporting reproductive outcomes of uterine-sparing surgery for patients with AD with fertility requirements. Surgical treatment was classified as complete excision or incomplete removal of AD and nonexcisional techniques for induction of necrosis in AD. The latter included physically removing the tissue where pathology is present or disrupting the blood flow to the affected area, involving high-intensity focused ultrasound, microwave ablation, radiofrequency ablation, and uterine artery embolization. Two independent researchers performed study selection according to the screening criteria. TABULATION, INTEGRATION, AND RESULTS: A total of 13 studies with 1319 patients with AD were included in this study, comprising 795 women wishing fertility. Pooled estimates of pregnancy, miscarriage, and live-birth rates after excisional treatment for women attempting to conceive were 40% (95% confidence interval [CI], 29-52), 21% (95% CI, 16-27), and 70% (95% CI, 64-76), respectively, and corresponding rates after nonexcisional treatment were 51% (95% CI, 42-60), 22% (95% CI, 13-34), and 71% (95% CI, 57-83), respectively. The differences were not statistically significant. CONCLUSION: Excisional treatment could be a treatment consideration for patients with symptomatic AD and infertility for several years or repeated failure of assisted reproductive technology. Nonexcisional techniques may be considered probably for AD-related infertility.
引用
- Jiang L, Han Y, Song Z, et al. Pregnancy Outcomes after Uterus-sparing Operative Treatment for Adenomyosis: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2023. PMID: 36972750. doi:10.1016/j.jmig.2023.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。